Global /South Korea /Healthcare /Drug Manufacturers - General /044820
chevron_leftBack
Cosmax BTI, Inc. logo

Cosmax BTI, Inc.

044820
KRX: 044820 Delayed
17,810KRW 0.1%
11.67 USD
As of 13 June 2026, Cosmax BTI, Inc. has a market cap of $111.83M USD, ranking #24759 globally and #1153 in South Korea. It ranks #2209 in the Healthcare sector, and #797 in the Drug Manufacturers - General industry.
Global Rank
24759
Country Rank
1153
Sector Rank
2209
Industry Rank
797
Key Stats
Market Cap
$111.83MUSD
170.08B KRW
Enterprise Value
$391.16MUSD
596.99B KRW
Revenue (TTM)
$424.25MUSD
645.21B KRW
EBITDA (TTM)
$35.74MUSD
54.54B KRW
Net Income (TTM)
$19.21MUSD
29.21B KRW
EBITDA Margin
8.5%
Profit Margin
4.5%
PE Ratio
5.8
PS Ratio
0.3
PB Ratio
0.6
EV/EBITDA
7.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Founded
1984
Website
cosmaxbti.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.1% 1.4% 9.9% 36% 20% 58%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
044820
코스맥스비티아이(주)
ISIN: KR7044820009
Shares Out.:
9.555M1 Shares Float: 2.846M2
TV:
SA:
YF:
GF:
BA:
MS:
17,810 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Cosmax BTI, Inc.

Cosmax BTI, Inc. engages in the research, development, production, and sale of cosmetics, health functional foods, pharmaceuticals, and special containers in South Korea. The company offers cosmetics products, including skincare, mask, cleansing, hair, bath and body, sun care, makeup, cushion, eye and lip makeup, nail, and fragrance products; baby and child cosmetic products; Korean herbal cosmetics; and cosmeceuticals. It also provides health supplement products in form of gels, capsules, and powders; and medical devices. In addition, the company exports its products. Cosmax BTI, Inc. was founded in 1984 and is headquartered in Seongnam-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)
Name
Market Cap diff.
PE
$9.15B
13.91T KRW
8K%
-
$6.77B
10.3T KRW
6K%
1958.1
$5.24B
7.97T KRW
5K%
29.9
298380
$4.96B
7.55T KRW
4K%
-
000100
$4.55B
6.92T KRW
4K%
35.9
$4.44B
6.76T KRW
4K%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
681K%
38.1
JNJ
$547.28B
489K%
26.4
ABBV
$360.63B
322K%
97.4
$321.52B
256.25B CHF
287K%
19.9
AZN
$288.84B
215.59B GBP
258K%
27.6
NOVN
$274.65B
218.9B CHF
245K%
20.5
chevron_leftBack